Persistent Mullerian duct syndrome
|
0.800 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Persistent Mullerian duct syndrome
|
0.800 |
Biomarker
|
disease |
CTD_human |
|
|
|
Cryptorchidism
|
0.180 |
Biomarker
|
disease |
HPO |
|
|
|
Male Pseudohermaphroditism
|
0.140 |
Biomarker
|
disease |
HPO |
|
|
|
Hernia, Inguinal
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Male infertility
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Abnormality of male internal genitalia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Adrenal hyperplasia, congenital, type 5
|
0.010 |
Biomarker
|
disease |
BEFREE |
The basic characteristics, mechanism of high plasma aldosterone concentration, steroid modification of Müllerian inhibiting substance and rationality of castration in a case of 17 alpha-hydroxylase deficiency are discussed.
|
1769794 |
1991 |
Persistent Mullerian duct syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
We have characterized the point mutation responsible for an AMH-negative PMDS in three siblings: a guanine to thymine transversion at position 2096 in the fifth exon changes a GAA triplet, coding for glutamic acid, to a TAA stop codon.
|
2023927 |
1991 |
Persistent Mullerian duct syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
Isolation of the human MIS receptor gene will facilitate the identification of human PMDS patients with normal levels of MIS that have mutations in the MIS receptor gene.
|
7828438 |
1994 |
Mullerian inhibiting factor deficiency
|
0.010 |
Biomarker
|
disease |
BEFREE |
The in vivo outcomes of ectopic MIS exposure or MIS deficiency illustrate the balance required to coordinately differentiate and cause regression of the respective male and female genital ducts.
|
7828438 |
1994 |
Persistent Mullerian duct syndrome
|
0.800 |
AlteredExpression
|
disease |
BEFREE |
PMDS has been attributed to deficient AMH activity or to abnormalities in the AMH receptor.
|
7907140 |
1994 |
Persistent Mullerian duct syndrome
|
0.800 |
Biomarker
|
disease |
BEFREE |
A rare form of familial male pseudohermaphroditism, the persistent Müllerian duct syndrome (PMDS) is characterized by persistence of uterus and Fallopian tubes in 46,XY phenotypic males and is ascribed to defects in the synthesis or action of anti-Müllerian hormone (AMH).
|
8162013 |
1994 |
Persistent Mullerian duct syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
Molecular genetics of the persistent müllerian duct syndrome: a study of 19 families.
|
8162013 |
1994 |
Male Pseudohermaphroditism
|
0.140 |
Biomarker
|
disease |
BEFREE |
A rare form of familial male pseudohermaphroditism, the persistent Müllerian duct syndrome (PMDS) is characterized by persistence of uterus and Fallopian tubes in 46,XY phenotypic males and is ascribed to defects in the synthesis or action of anti-Müllerian hormone (AMH).
|
8162013 |
1994 |
Sex Differentiation Disorders
|
0.060 |
Biomarker
|
group |
BEFREE |
Thirty-one patients with intersex and gonadal anomalies from 17 institutions were therefore evaluated between 1989 and 1992 with an MIS enzyme-linked immunosorbent assay (ELISA).
|
8468660 |
1993 |
granulosa cell tumor
|
0.050 |
Biomarker
|
disease |
BEFREE |
Finally, two young girls with ovarian granulosa cell tumors had elevated MIS values that fell from 18 to 2 ng/mL and from 6.5 to 1 ng/mL during postoperative follow-up.(ABSTRACT TRUNCATED AT 250 WORDS)
|
8468660 |
1993 |
Congenital absence of both testes
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Serum MIS levels correlated with the presence of testicular tissue in two patients with suspected anorchia, five patients with male pseudohermaphroditism, and eight other intersex patients with undescended testes, dysgenetic gonads, or ovotestes.
|
8468660 |
1993 |
Turner Syndrome
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, secretion of AMH is a constitutive feature of the immature Sertoli cell and its expression is altered only by mutations of the AMH gene, but not by gonadal dysgenesis.
|
8623936 |
1996 |
Sex Differentiation Disorders
|
0.060 |
Biomarker
|
group |
BEFREE |
Anti-Müllerian hormone (AMH) immunoreactivity was studied on paraffin sections obtained from archival testicular biopsies of 29 children with intersex disorders and of 22 controls.
|
8623936 |
1996 |
Gonadal Dysgenesis
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
In conclusion, secretion of AMH is a constitutive feature of the immature Sertoli cell and its expression is altered only by mutations of the AMH gene, but not by gonadal dysgenesis.
|
8623936 |
1996 |
Streak gonad
|
0.030 |
Biomarker
|
disease |
BEFREE |
In patients with asymmetric gonadal differentiation, the streak gonad was AMH-negative.
|
8623936 |
1996 |
Gonadoblastoma
|
0.010 |
Biomarker
|
disease |
BEFREE |
AMH immunoreactivity was conserved in premeiotic seminiferous tubules of dysgenetic testes, and also in sex-cord cells of a gonadoblastoma.
|
8623936 |
1996 |
Testicular dysgenesis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Testicular dysgenesis does not affect expression of anti-müllerian hormone by Sertoli cells in premeiotic seminiferous tubules.
|
8623936 |
1996 |
Persistent Mullerian duct syndrome
|
0.800 |
GeneticVariation
|
disease |
UNIPROT |
A 27 base-pair deletion of the anti-müllerian type II receptor gene is the most common cause of the persistent müllerian duct syndrome.
|
8872466 |
1996 |